BioLife Solutions - About the company
BioLife Solutions is a public company based in Bothell (United States), founded in 1987. It operates as a Developer of cell and gene therapies with the integrity of a single cell. BioLife Solutions has raised an undisclosed amount in funding. The company has 450 active competitors, including 59 funded and 77 that have exited. Its top competitors include companies like Illumina, Quanterix and Biocare Medical.
Company Details
Developer of cell and gene therapies with the integrity of a single cell. The company provides biopreservation media like CryoStor Freeze Media, which supports clinical applications and maximizes post-thaw cell viability. Additional solutions include HypoThermosol for hypothermic storage, ThawSTAR automated thawing devices, and closed-system cell processing tools.
- Website
- www.biolifesolutions.com/
- Social
- Email ID
- *****@biolifesolutions.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
1987
Location
Bothell, United States
Stage
Public
Latest Funding Round
Ranked
3rd among 450 active competitors
Annual Revenue
$96.2M as on Dec 31, 2025
Employee Count
192 as on Apr 30, 2026
Exit Details
Public
Legal entities associated with BioLife Solutions
BioLife Solutions is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BioLife Solutions Inc CIN: 94-3076866 , United States, Active | Nov 04, 1987 | $96.2M (As on Dec 31, 2025) | 409 (As on Dec 31, 2023) | - |
BIOLIFE SOLUTIONS, INC CIN: 943076866 , United States, Active | Dec 31, 1999 | - | 321 (As on Dec 31, 2024) | - |
Biolife Solutions, Inc. CIN: 0018y00000BnLTeAAN , United States, Active | May 02, 2024 | - | - | - |
BioLife Solutions's IPO details
BioLife Solutions got listed on Nov 22, 1989.
Click here to take a look at BioLife Solutions's IPO in detail
Sign up to download BioLife Solutions' company profile
BioLife Solutions's funding and investors
BioLife Solutions has raised funding over 2 rounds. Its first funding round was on Apr 30, 2018.
Here is the list of recent funding rounds of BioLife Solutions:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 27, 2023 | 3324577 | Post IPO | 4499279 | 1144177 | 8449453 | 7485406 |
Apr 30, 2018 | 4642678 | Post IPO | 1340548 | 1777671 | 3513970 | 1725548 |
Access funding benchmarks and valuations. Sign up today!View details of BioLife Solutions's funding rounds and investors
BioLife Solutions' founders and board of directors
Founder? Claim ProfileBioLife Solutions' employee count trend
BioLife Solutions has 192 employees as of Apr 26. Here is BioLife Solutions's employee count trend over the years:
Uncover BioLife Solutions' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioLife Solutions's Competitors and alternates
Top competitors of BioLife Solutions include Illumina, Quanterix and Biocare Medical. Here is the list of Top 10 competitors of BioLife Solutions, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 71/100 | |
2nd | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 71/100 | |
3rd | BioLife Solutions 1987, Bothell (United States), Public | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
4th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 65/100 | |
5th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 64/100 | ||
6th |  Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 63/100 | |
7th | Mapi Pharma 2008, Ness Ziona (Israel), Series B | Clinical stage pharmaceutical company developing extended release versions of generic drugs. | $60M | 62/100 | |
8th | RoosterBio 2012, Frederick (United States), Series B | Developer of human mesenchymal stem cells and extracellular vesicles | $38.4M | 61/100 | |
9th | Siemens Healthineers 1847, Forchheim (Germany), Public | Developer of AI-based medical diagnostic products for the healthcare sector | - | 60/100 | |
10th | Bio-Techne 1981, Minneapolis (United States), Public | Developer of biotech reagents, instruments and clinical diagnostic products | - | 59/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on BioLife Solutions's competitors? Click here to see the top ones
BioLife Solutions's Investments and acquisitions
BioLife Solutions has made 8 investments in companies including Pluristyx and iVexSol. BioLife Solutions has also acquired 5 companies including PanTHERA CryoSolutions and Sexton Biotechnologies.Here is the list of investments & acquisitions:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 28, 2025 | Investments | 2015 | Seattle (United States) | |
Apr 07, 2025 | Acquisition | 2018 | Edmonton (Canada) | |
Jan 26, 2023 | Investments | 2018 | Toronto (Canada) |
_1574938149640.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by BioLife Solutions
Reports related to BioLife Solutions
Here is the latest report on BioLife Solutions's sector:
News related to BioLife Solutions
Filter this listMedia has covered BioLife Solutions for a total of 14 events in the last 1 year, 8 of them have been about company updates.
•
•
BioLife Solutions Signs Supply Agreement with Qkine LimitedBenzinga•Feb 12, 2026•Qkine, BioLife Solutions
•
Stephens Investment Management Group LLC Acquires 237,097 Shares of Maximus, Inc. $MMSMarketBeat•Jan 17, 2026•Maximus, Stephens Investment Management Group, Palomar Specialty Insurance, Ryan Specialty and 13 others
•
•
•
Peli BioThermal expands cold chain capabilities with EVO acquisitionFreightWaves•Oct 08, 2025•BioLife Solutions, Peli BioThermal
•
•
•
Cetera Investment Advisers Invests $299,000 in BioLife Solutions, Inc. $BLFSMarketBeat•Aug 23, 2025•BioLife Solutions, Cetera
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about BioLife Solutions
Explore our recently published companies
- hominin labs - London based, 2023 founded, Funding Raised company
- BioImaginix - Morgantown based, 2024 founded, Funding Raised company
- Edenbros - United States based, 2009 founded, Funding Raised company
- EPCO Sales - Middlebury based, 1978 founded, Funding Raised company
- noLimit Foundation - Seed company
- Institute for Rural Initiatives - Senegal based, 2017 founded, Funding Raised company
